Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Basilea Pharmaceutica Ltd. (develops antibacterial, antifungal, and dermatological therapeutics) raised CHF205.8mm ($161.2mm) with an IPO of 2.1mm shares priced at CHF98 on the Swiss SWX market. The company's proposed price range when it filed earlier this month was CHF90-115; it originally sought to raise CHF189-241.5mm.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?